News & Updates
Filter by Specialty:
Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers
Use of telbivudine (LdT) during the second trimester of pregnancy helps prevent mother-to-child transmission of hepatitis B virus, reveals a study. In addition, treatment with LdT during pregnancy is safe in the long term for both mothers and infants.
Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers
20 Mar 2023
Add-on amantadine of no help in hospitalized COVID-19 patients
The addition of amantadine to standard care falls short of improving the likelihood of recovery of patients hospitalized with COVID-19, according to a study.
Add-on amantadine of no help in hospitalized COVID-19 patients
20 Mar 2023
Frequent aspirin use protects against ovarian cancer even in women with genetic predisposition
Genetic susceptibility to ovarian cancer does not appear to modify the protective association between frequent aspirin use and the risk of developing the cancer, as shown in a study.
Frequent aspirin use protects against ovarian cancer even in women with genetic predisposition
19 Mar 2023
How accurate is PPI test in GERD, chest pain diagnosis?
Use of the proton pump inhibitor (PPI) test showed acceptable sensitivity but poor specificity in diagnosing gastroesophageal reflux disease (GERD), a study has shown. The test, however, works better in GERD-related noncardiac chest pain (NCCP).
How accurate is PPI test in GERD, chest pain diagnosis?
19 Mar 2023
Vitamin E supplements a cure for rheumatoid arthritis?
Supplementation with vitamin E fixes the intestinal barrier and the gastrointestinal tract, which then helps prevent and treat rheumatoid arthritis (RA), reveals a study.
Vitamin E supplements a cure for rheumatoid arthritis?
18 Mar 2023
Triple combination asthma inhaler works in patients with persistent airflow limitation
A novel once-a-day inhaler for asthma that contains a fixed-dose combination of the corticosteroid mometasone furoate (MF), the long-acting beta-agonist indacaterol acetate (IND), and the long-acting muscarinic antagonist glycopyrronium bromide (GLY) appears to have a favourable effect in patients with persistent airflow limitation (PAL), according to a post hoc analysis of the IRIDIUM study.
